Quick Answer
AVANOS MEDICAL, INC. reported Long Term Debt of $90.30 million for the year ending 2025.
- AVANOS MEDICAL, INC. showed a decrease of -27.9% in Long Term Debt from 2024 to 2025.
- This data is from AVANOS MEDICAL, INC.'s annual report (Form 10-K), filed with the SEC on February 24, 2026.
- XBRL data for this metric is available from 2013 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2015: $631.40 million | Q2 2015: $585.80 million | Q3 2015: $585.90 million | Q1 2016: $578.50 million | Q2 2016: $624.00 million | Q3 2016: $589.40 million | Q1 2017: $579.40 million | Q2 2017: $579.90 million | Q3 2017: $580.40 million | Q1 2018: $542.00 million | Q2 2018: $247.40 million | Q3 2018: $247.60 million | Q4 2018: $247.70 million | Q1 2019: $247.90 million | Q2 2019: $247.80 million | Q3 2019: $247.90 million | Q1 2020: $248.20 million | Q2 2020: $248.40 million | Q3 2020: $248.50 million | Q1 2021: $175.00 million | Q2 2021: $165.00 million | Q3 2021: $145.00 million | Q4 2021: $130.00 million | Q1 2022: $254.40 million | Q2 2022: $249.30 million | Q3 2022: $247.80 million | Q1 2023: $204.70 million | Q2 2023: $203.30 million | Q3 2023: $258.30 million | Q1 2024: $167.20 million | Q2 2024: $164.90 million | Q3 2024: $152.60 million | Q1 2025: $98.00 million | Q2 2025: $95.70 million | Q3 2025: $93.40 million.
- Historical annual values: Fiscal year 2025: $90.30 million | Fiscal year 2024: $125.30 million | Fiscal year 2023: $159.40 million | Fiscal year 2022: $226.30 million | Fiscal year 2022: $226.30 million | Fiscal year 2021: $130.00 million | Fiscal year 2021: $130.00 million | Fiscal year 2020: $180.00 million | Fiscal year 2019: $248.10 million | Fiscal year 2019: $248.10 million | Fiscal year 2018: $247.70 million | Fiscal year 2017: $541.10 million | Fiscal year 2016: $579.00 million | Fiscal year 2015: $578.10 million | Fiscal year 2014: $622.60 million | Fiscal year 2013: $0.00.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: